David Burns to Drug Administration Schedule
This is a "connection" page, showing publications David Burns has written about Drug Administration Schedule.
Connection Strength
0.089
-
Joyce AM, Burns DL. Recurrent Clostridium difficile colitis. Compr Ther. 2004 Fall-Winter; 30(3):160-3.
Score: 0.053
-
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018 11; 15(11):e1002690.
Score: 0.035